Gempharmatech

Gempharmatech company information, Employees & Contact Information

Explore related pages

Related company profiles:

GemPharmatech Co. Ltd., founded in 2017, is an international biotechnology enterprise specializing in the development of humanized animal models. The management and operation team has nearly 20 years of experience in gene-editing technology and animal production. GemPharmatech provides a one-stop service as model customization, breeding, phenotyping, and pharmacology for the biomedical research community. The company has developed the world's most abundant mouse strains resource to inspire scientific innovation and drive drug discovery.
Looking for a particular Gempharmatech employee's phone or email?

Gempharmatech Questions

News

GemPharmatech announces research collaboration with leading cancer center to advance antibody discovery - PR Newswire

GemPharmatech announces research collaboration with leading cancer center to advance antibody discovery PR Newswire

Chinese CRO GemPharmatech expands in San Diego as industry weighs FDA's animal testing shift - Fierce Biotech

Chinese CRO GemPharmatech expands in San Diego as industry weighs FDA's animal testing shift Fierce Biotech

GemPharmatech Significantly Expands U.S. Capabilities with New San Diego Biotech Hub Facility - PR Newswire

GemPharmatech Significantly Expands U.S. Capabilities with New San Diego Biotech Hub Facility PR Newswire

China's MGI Tech, GemPharmatech defend themselves after US bill proposed - Reuters

China's MGI Tech, GemPharmatech defend themselves after US bill proposed Reuters

Diamine oxidase acts as a novel risk factor in abnormal inflammation via mediating “cytosolic ROS-autophagy-IFN-γ” axis in NK cells - ScienceDirect.com

Diamine oxidase acts as a novel risk factor in abnormal inflammation via mediating “cytosolic ROS-autophagy-IFN-γ” axis in NK cells ScienceDirect.com

GemPharmatech's Board Appoints Brandy Wilkinson, Ph.D. as its New Chief Executive Officer of GemPharmatech LLC. - BioSpace

GemPharmatech's Board Appoints Brandy Wilkinson, Ph.D. as its New Chief Executive Officer of GemPharmatech LLC. BioSpace

GemPharmatech Announces Research Collaboration with Memorial Sloan Kettering Cancer Center to Advance Antibody Discovery - MarketScreener

GemPharmatech Announces Research Collaboration with Memorial Sloan Kettering Cancer Center to Advance Antibody Discovery MarketScreener

GemPharmatech, Leading Provider of Genetically Engineered Mouse Models, Goes Public on Shanghai Stock Exchange - Business Wire

GemPharmatech, Leading Provider of Genetically Engineered Mouse Models, Goes Public on Shanghai Stock Exchange Business Wire

GemPharmatech Teams Up With Memorial Sloan Kettering to Advance Antibody Innovation - MSN

GemPharmatech Teams Up With Memorial Sloan Kettering to Advance Antibody Innovation MSN

New mouse model for preclinical research in human IL-12 therapy - BioWorld MedTech

New mouse model for preclinical research in human IL-12 therapy BioWorld MedTech

Animal Models and Microfluidic Tools with a Human Touch - Genetic Engineering and Biotechnology News

Animal Models and Microfluidic Tools with a Human Touch Genetic Engineering and Biotechnology News

Introducing NeoMab™: GemPharmatech's Innovative Antibody Gene Humanized Mouse Model - BioSpace

Introducing NeoMab™: GemPharmatech's Innovative Antibody Gene Humanized Mouse Model BioSpace

Top Gempharmatech Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant